Today: 21 July 2026
Ondas Inc (ONDS) stock slips as Singapore Airshow defense rollout comes into focus
30 January 2026
2 mins read

Ondas Inc (ONDS) stock slips as Singapore Airshow defense rollout comes into focus

New York, Jan 30, 2026, 09:32 EST — Regular session

  • Shares of Ondas dipped in early trading following the company’s announcement of a new Defense and Security product ahead of next week’s Singapore Airshow.
  • The company is offering a unified “multi-domain” package that covers drones, ground robots, and counter-drone tools.
  • After a recent $1 billion stock-and-warrant financing, investors want to see follow-through on orders.

Shares of Ondas Inc slipped roughly 8% to $11.27 in early Nasdaq action Friday. The drop came after the company announced plans to officially unveil a new defense and security product at next week’s Singapore Airshow.

The timing is crucial. Ondas is pushing to reposition itself as a defense-tech supplier right when governments and contractors are ramping up their focus on drones and counter-drone tech, while investors grow increasingly impatient with long-term product timelines.

The company has faced scrutiny following a sizable equity-and-warrant deal earlier this month, a move that can weigh on the stock by boosting the potential share count if those warrants get exercised.

Ondas revealed its Singapore Airshow launch will feature updated branding, a 2026 product and technology roadmap, and what it described as a “comprehensive solution portfolio” targeting defense, homeland security, and public safety sectors. The company aims to promote a unified operating domain that integrates low-altitude and ground threats. https://ir.ondas.com/press-releases/detail…

“Modern threats are no longer confined to air or ground,” Eric Brock, Ondas’ chairman and CEO, said in the statement. Oshri Lugassy, another company executive, added their solution aims to help organizations “detect, decide, and act faster” while reducing operator numbers. https://ir.ondas.com/press-releases/detail…

Two days ago, Ondas announced that its American Robotics unit’s Optimus drone earned “Blue List” status. The designation is expected to accelerate federal purchases through the Defense Contract Management Agency’s Blue UAS cleared list. Blue UAS serves as a Defense Department screening program for drones and parts, linked to supply-chain and cybersecurity criteria outlined in the National Defense Authorization Act, the annual defense policy legislation. https://ir.ondas.com/press-releases/detail…

The Defense Innovation Unit announced that the Blue UAS cleared list is moving over to DCMA.

Ondas wrapped up a registered direct offering in mid-January, pulling in roughly $959.2 million in net proceeds. The deal included sales of shares and pre-funded warrants, along with common stock warrants. The company noted that if these warrants are fully exercised for cash, they could bring in more funds, though that’s far from guaranteed.

Yet, the same financing that boosts liquidity can also ramp up dilution risk. Warrants may limit price spikes if investors anticipate fresh stock hitting the market, while defense procurement often moves at a sluggish, unpredictable pace, with contracts slow to convert into actual revenue.

The Singapore Airshow, set for Feb. 3-8, is drawing major aerospace and defense firms amid rising regional security tensions and ambitions for airline expansion, Reuters reported. Byron Callan, managing partner at Capital Alpha Partners, told Reuters the key issue is “how will Asian countries assess what the U.S. defence commitment is to the region.” https://www.reuters.com/world/asia-pacific…

Investors in Ondas will be on the lookout for solid customer wins or partnership news linked to the event — and if the company’s fresh pitch actually drives order flow instead of just another rebranding effort.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • FBT ETF Draws $441.5 Million as CORT, VCYT, NEO Advance
    July 21, 2026, 11:47 AM EDT. The First Trust NYSE Arca Biotechnology Index Fund (FBT) recorded a $441.5 million inflow, marking a 16.0% week-over-week increase in units. Notable gainers among its main holdings were Corcept Therapeutics (CORT) rising 3.9%, Veracyte Inc (VCYT) climbing 3.2%, and NeoGenomics Inc (NEO) up 2.5%. FBT last traded at $248.68, approaching its 52-week peak of $258.20.
Imperial Brands share price slips as €900m bond terms land; buyback and dividend dates next for IMB
Previous Story

Imperial Brands share price slips as €900m bond terms land; buyback and dividend dates next for IMB

BP share price: What to know after Whiting refinery union vote, with OPEC+ and earnings ahead
Next Story

BP share price: What to know after Whiting refinery union vote, with OPEC+ and earnings ahead

Go toTop